Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy.
about
Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Increased baseline RUNX2, casp ...... ponse to methotrexate therapy.
@en
Increased baseline RUNX2, casp ...... ponse to methotrexate therapy.
@nl
type
label
Increased baseline RUNX2, casp ...... ponse to methotrexate therapy.
@en
Increased baseline RUNX2, casp ...... ponse to methotrexate therapy.
@nl
prefLabel
Increased baseline RUNX2, casp ...... ponse to methotrexate therapy.
@en
Increased baseline RUNX2, casp ...... ponse to methotrexate therapy.
@nl
P2093
P2860
P356
P1476
Increased baseline RUNX2, casp ...... ponse to methotrexate therapy.
@en
P2093
Dmitry E Karateev
Elena A Taskina
Natalia V Demidova
Svetlana I Glukhova
P2860
P304
P356
10.1111/1756-185X.13131
P577
2017-07-25T00:00:00Z